CELLNOVO (EGFF)

Promoteur – Intermédiaire Financier

CELLNOVO GROUP SA

Lieu

• France

Description

Investment in Cellnovo's facilities in order to develop its innovative connected all-in-one diabetes management system focused primarily on type 1 diabetes patients

Objectifs

The aim of the project is to scale up production of Cellnovo's novel micro-pump for type 1 diabetes patients and support related capital expenditure for products it plans to bring to the market in the future.

Secteur(s)

• Services - Activités spécialisées, scientifiques et techniques

Montant BEI envisagé (montant approximatif)

EUR 20 million

Coût total (montant approximatif)

EUR 41 million

Aspects environnementaux

All project activities are expected to be carried out in existing facilities without changing the already authorised scope and would therefore not require an environmental impact assessment (EIA) under Directive 2014/52/EU amending the EIA Directive 2011/92/EU.

Passation des marchés

The promoter has been assessed by the EIB as being a private company not subject to EU rules on public procurement or concessions.

Statut

Signé - 7/07/2017